Inventor · disambiguated record
Christopher Diorio
Also filed as: DIORIO CHRISTOPHER · DIORIO CHRISTOPHER R · DIORIO CHRISTOPHER RICHARD
21 granted patents·14 pending applications·60 citations·filing 2005–2021
93Inventor score
Top patents by PatentIndex Score
35 records- 0192US10166187B2Curcumin solid lipid particles and methods for their preparation and useCAPSUGEL BELGIUM NV·Filed 2017·Granted Jan 1, 2019·5 cites·13 claims
- 0291US9532952B2Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredientsPHYSICIAN'S SEAL LLC·Filed 2016·Granted Jan 3, 2017·5 cites·6 claims
- 0389US9314461B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2013·Granted Apr 19, 2016·9 cites·40 claims
- 0489US8524276B2Oral formulations and lipophilic salts of methylnaltrexoneSHAH SYED M·Filed 2011·Granted Sep 3, 2013·11 cites·27 claims
- 0587US10143654B2Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredientsPHYSICIANS SEAL LLC·Filed 2016·Granted Dec 4, 2018·2 cites·16 claims
- 0687US8956651B2Oral formulations and lipophilic salts of methylnal trexoneWYETH LLC·Filed 2013·Granted Feb 17, 2015·6 cites·31 claims
- 0786US11324699B2Lipid multiparticulate formulationsCAPSUGEL BELGIUM NV·Filed 2015·Granted May 10, 2022·3 cites·14 claims
- 0884US10307417B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2018·Granted Jun 4, 2019·2 cites·29 claims
- 0980US10507206B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2019·Granted Dec 17, 2019·1 cites·25 claims
- 1079US10376505B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2018·Granted Aug 13, 2019·1 cites·30 claims
- 1179US8524281B2Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrheaVENKATA RAMANA RAO SRIPRIYA·Filed 2010·Granted Sep 3, 2013·11 cites·15 claims
- 1278US7771744B2Bazedoxifene acetate formulationsWYETH LLC·Filed 2006·Granted Aug 10, 2010·3 cites·47 claims
- 1377US2020121673A1Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2019·Application pending·0 cites
- 1476US11701425B2Valerian composition and related methodsNESTLE SA·Filed 2021·Granted Jul 18, 2023·0 cites·6 claims
- 1575US11141484B2Valerian composition and related methodsPHYSICIANS SEAL LLC·Filed 2019·Granted Oct 12, 2021·0 cites·7 claims
- 1675US11141485B2Valerian composition and related methodsPHYSICIANS SEAL LLC·Filed 2019·Granted Oct 12, 2021·0 cites·11 claims
- 1772US7709024B2Sustained-release formulation and uses thereofSOLVAY PHARM BV·Filed 2006·Granted May 4, 2010·1 cites·9 claims
- 1871US10888522B2Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredientsPHYSICIANS SEAL LLC·Filed 2018·Granted Jan 12, 2021·0 cites·23 claims
- 1962US2016000714A1Curcumin solid lipid particles and methods for their preparation and useCAPSUGEL BELGIUM NV·Filed 2014·Application pending·0 cites
- 2061US10342873B2Valerian composition and related methodsPHYSICIANS SEAL LLC·Filed 2017·Granted Jul 9, 2019·0 cites·7 claims
- 2159US2016206612A1Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2016·Application pending·0 cites
- 2255US2017231940A1Multiparticulate L-Carnitine And Nootropic Compositions And Related MethodsPHYSICIAN'S SEAL LLC·Filed 2017·Application pending·0 cites
- 2354US7595310B2Glucuronate salt of a piperazine compoundSOLVAY PHARM BV·Filed 2006·Granted Sep 29, 2009·0 cites·25 claims
- 2453US7615551B2Salicylate and gentisate salts of a piperazine compoundSOLVAY PHARM BV·Filed 2006·Granted Nov 10, 2009·0 cites·25 claims
- 2553US2016015647A1Bismuth liquid filled hard capsulesCAPSUGEL BELGIUM NV·Filed 2014·Application pending·0 cites
- 2652US2006223791A1O-desmethylvenlafaxine and bazedoxifene combination product and uses thereofWYETH CORP·Filed 2006·Application pending·0 cites
- 2750US9211264B2Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrheaWYETH LLC·Filed 2013·Granted Dec 15, 2015·0 cites·9 claims
- 2850US2022062163A1Effervescent tabletsPHARMACANNIS LABS LLC·Filed 2021·Application pending·0 cites
- 2946US2007259041A1Solid dosage formulationsWYETH CORP·Filed 2007·Application pending·0 cites
- 3045US2008014256A1Oral formulations comprising tigecyclineWYETH CORP·Filed 2006·Application pending·0 cites
- 3145US2007014859A1Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinateWYETH CORP·Filed 2006·Application pending·0 cites
- 3244US2019015346A1Self-emulsifying drug delivery systemPHARMACANNIS LABS LLC·Filed 2018·Application pending·0 cites
- 3344US2017319476A1Floating Zinc Gastric Delivery CompositionsPHYSICIAN'S SEAL LLC·Filed 2017·Application pending·0 cites
- 3444US2010221445A1O-desmethylvenlafaxine and bazedoxifene combination product and uses thereofWYETH LLC·Filed 2010·Application pending·0 cites
- 3542US2005175698A1Multiparticulate O-desmethylvenlafaxine salts and uses thereofWYETH CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Diorio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →